Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties
Despite the global stabilization of the number of new HIV infections in recent years, there has been an increase in new infections among men who have sex with men. This fact indicates the lack of effectiveness of the measures and prevention campaigns established so far for this group. It is therefo...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-09-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/10821.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846146032844406784 |
|---|---|
| author | Santiago Moreno Guillen María Jesús Vivancos Gallego Matilde Sanchez Conde |
| author_facet | Santiago Moreno Guillen María Jesús Vivancos Gallego Matilde Sanchez Conde |
| author_sort | Santiago Moreno Guillen |
| collection | DOAJ |
| description | Despite the global stabilization of the number of new HIV infections in recent years, there has been an increase in new infections among men who have sex with men. This fact indicates the lack of effectiveness of the measures and prevention campaigns established so far for this group. It is therefore necessary to implement alternative preventive measures for them. Pre-exposure pharmacological prophylaxis (PrEP) is one of the best evaluated options and has had high protection rates in both clinical and real-life trials. The strategy has also shown an adequate profile in terms of safety, tolerance, adverse effects and cost-effectiveness in the studies carried out to assess this important topic. |
| format | Article |
| id | doaj-art-7c642b0f12404f898462b683d5c4a47a |
| institution | Kabale University |
| issn | 1130-6343 2171-8695 |
| language | English |
| publishDate | 2017-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Farmacia Hospitalaria |
| spelling | doaj-art-7c642b0f12404f898462b683d5c4a47a2024-12-02T04:55:26ZengElsevierFarmacia Hospitalaria1130-63432171-86952017-09-0141563063710.7399/fh.10821Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertaintiesSantiago Moreno Guillen0María Jesús Vivancos Gallego1Matilde Sanchez Conde2Infectious Disease Unit, Hospital Ramón y Cajal, Madrid. Instituto Ramón y Cajal de Investigación Sanitaria (Ramón y Cajal Health Research Institute) (IRYCIS), Madrid. Department of Medicine, University of Alcalá de Henares, Madrid.Infectious Disease Unit, Hospital Ramón y Cajal, Madrid. Instituto Ramón y Cajal de Investigación Sanitaria (Ramón y Cajal Health Research Institute) (IRYCIS), MadridInfectious Disease Unit, Hospital Ramón y Cajal, Madrid. Instituto Ramón y Cajal de Investigación Sanitaria (Ramón y Cajal Health Research Institute) (IRYCIS), Madrid.Despite the global stabilization of the number of new HIV infections in recent years, there has been an increase in new infections among men who have sex with men. This fact indicates the lack of effectiveness of the measures and prevention campaigns established so far for this group. It is therefore necessary to implement alternative preventive measures for them. Pre-exposure pharmacological prophylaxis (PrEP) is one of the best evaluated options and has had high protection rates in both clinical and real-life trials. The strategy has also shown an adequate profile in terms of safety, tolerance, adverse effects and cost-effectiveness in the studies carried out to assess this important topic.http://www.aulamedica.es/fh/pdf/10821.pdfPre-exposure prophylaxisHIV infectionEfficacy |
| spellingShingle | Santiago Moreno Guillen María Jesús Vivancos Gallego Matilde Sanchez Conde Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties Farmacia Hospitalaria Pre-exposure prophylaxis HIV infection Efficacy |
| title | Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties |
| title_full | Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties |
| title_fullStr | Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties |
| title_full_unstemmed | Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties |
| title_short | Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties |
| title_sort | pre exposure prophylaxis prep against hiv efficacy safety and uncertainties |
| topic | Pre-exposure prophylaxis HIV infection Efficacy |
| url | http://www.aulamedica.es/fh/pdf/10821.pdf |
| work_keys_str_mv | AT santiagomorenoguillen preexposureprophylaxisprepagainsthivefficacysafetyanduncertainties AT mariajesusvivancosgallego preexposureprophylaxisprepagainsthivefficacysafetyanduncertainties AT matildesanchezconde preexposureprophylaxisprepagainsthivefficacysafetyanduncertainties |